Guideline webposted: November 2023
Read Full-Text Guideline
This multi-society guideline addresses key clinical questions on the use of induction chemotherapy, chemotherapy versus chemoradiation prior to surgery, optimal radiation dose, the value of esophagectomy, timing of esophagectomy, the approach and extent of lymphadenectomy, the use of minimally invasive esophagectomy and the value of adjuvant therapy after resection.
Developed in collaboration with:
We have recently updated our privacy policy and terms of use. By using this site, you agree to ASTRO’s Privacy Policy and Terms of Use. We use cookies to provide, secure and improve our services to you. To learn more, click here.